• Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism
  • Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism
  • Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism
  • Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism
  • Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism
  • Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism

Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism

Powder: Yes
Customized: Non-Customized
Certification: Enterprise Standards
Suitable for: Adult
State: Powder
Purity: >98%
Customization:
Diamond Member Since 2016

Suppliers with verified business licenses

Rating: 5.0/5
Manufacturer/Factory, Trading Company
  • Overview
  • Packaging & Shipping
  • Our service
Overview

Basic Info.

Model NO.
CAS 131918-61-1
Color
White
Grade
Pharmaceutical Grade
Shelf Life
2 Years
Model No
Hhd
Transport Package
Alumininum Foli Bags
Specification
10g, 50g, 200g, 1kg, 5kg
Trademark
hhdpharm
Origin
China

Product Description

Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary HyperparathyroidismActive vitamin D drugs are a general term for a series of vitamin D2/D3 derivatives, commonly referred to as "calciferol" drugs. These compounds are complex in structure and involve techniques such as photochemistry and microbial transformation. They are difficult to synthesize, sensitive to light and oxygen, and the API in the preparation is microgram-level, and the development threshold is high. Clinically used mainly for the treatment of osteoporosis, secondary hyperparathyroidism and psoriasis.
Paricalcitol was launched as Zemplar in the US for the prevention and treatment of secondary hyperthyroidism associated with chronic renal failure. Paricalcitol is a synthetic vitamin D2, namely a novel 1-alpha-hydroxy-19-noranalogue in which the ring A exocyclic methylene group, typical of all vitamin D systems, has been replaced by two hydrogen atoms. Paricalcitol is the first vitamin D analogue marketed for this indication. In patients with chronic renal failure, Paricalcitol appreciably reduced levels of parathyroid hormone (PTH) without a significant difference in the incidence rate for hypercalcemia or hyperphosphatemia when compared with placebo. 
Product Name: Paricalcitol
Synonyms: PARICALCITOL (10 MG)F0E3030.997MG/MG(AI);
19-nor-1alpha,25-dihydroxyvitamin D2;(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-Hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol;
Zemplar;
CAS: 131918-61-1
Molecular Structure: Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism
Appearance White or off-white powder
MF: C27H44O3
MW: 416.64
EINECS: 658-064-6
Product Categories: Vitamin D3 analogs;Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals

Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism
Fp  14ºC
Form  Neat
InChIKey BPKAHTKRCLCHEA-UBFJEZKGSA-N
Quality Standard USP41
 
1) Synthetic analog of vitamin D. Antihyperparathyroid.
2) Antihyperparathyriod
3) 1,25-Dihydroxy vitamin D2 is a potent agonist of the vitamin D receptor. Paricalcitol is a synthetic 1,25-dihydroxy vitamin D2 analog. As vitamin D deficiency, associated with chronic kidney disease, leads to an increase in parathyroid hormone (secondary hyperparathyroidism), paricalcitol is used in renal patients to block parathyroid hormone overproduction. Vitamin D deficiency is also a risk factor in cancer, cardiovascular disease, hypertension, and diabetes, and paricalcitol may have applications in those contexts as well.


Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism

Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism
It is used for the prevention and treatment of SHPT, and the prevention and treatment of SHPT in patients with stage III and IV chronic kidney disease (CKD) before dialysis and transplantation.

Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism


Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism
Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism

Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism


Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism
Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism


Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism

Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism
Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism

 



Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary HyperparathyroidismHhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary HyperparathyroidismHhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary HyperparathyroidismHhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary HyperparathyroidismHhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism

Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism
Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism

Packaging & Shipping

Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism

Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism
Our service

Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism1.COA/MSDS/ROS/MOA Available.
2.Any inquiries will be replied within 12 hours.
3. Dedication to quality, supply & service.
4.Strictly on selecting raw materials.
5.Reasonable & competitive price, fast lead time.
6.Faster delivery:Sample order in stock and one week for bulk production.
7.We have strong cooperation with DHL, TNT, UPS, FEDEX, EMS. Or you also can choose your own shipping forwarder.
8.Timely after-service resolves your worry for internation trade.
9.Payment:Hhdpharm Paricalcitol CAS 131918-61-1 with High Purity 99.0%Min. Small Molecule Compounds Secondary Hyperparathyroidism

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2016

Suppliers with verified business licenses

Rating: 5.0/5
Manufacturer/Factory, Trading Company
Registered Capital
1000000 RMB
Plant Area
501~1000 square meters